MedTrace Logo

Remote Preconditioning and Myocardial Protection

NCT02877238 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2017-12-13

No results posted yet for this study

Summary

Remote ischemic preconditioning (RIPC) of the myocardium by limb ischemia/reperfusion may mitigate cardiac damage, but its interaction with the anesthetic regimen is unknown.

Conditions

  • Congenital Heart Disease

Interventions

DRUG

Sevoflurane plus remote ischemic preconditioning

Inhalational anesthesia (Sevoflurane) in addition to remote ischemic preconditioning

DRUG

Total intravenous anesthesia plus remote ischemic preconditioning

Total intravenous anesthesia (propofol plus fentanyl) in addition to remote ischemic preconditioning

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Sayed K Abd-Elshafy, MD · Associate professor of anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02877238 on ClinicalTrials.gov